Post-acute infection syndromes may develop after acute viral disease 1 . Infection with
SARS-CoV-2 can result in the development of a post-acute infection syndrome known as long …

The importance of microtubules in mitosis makes them a superb target for a group of highly
successful, chemically diverse anticancer drugs. Knowledge of the mechanistic differences …

The development of resistance to paclitaxel in tumors is one of the most significant obstacles
to successful therapy. Overexpression of the βIII-tubulin isotype has been associated with …

Target-mediated toxicity constitutes a major limitation for the development of therapeutic
antibodies. To redirect the activity of antibodies recognizing widely distributed targets to the site …

E7389, which is in phase I and II clinical trials, is a synthetic macrocyclic ketone analogue of
the marine sponge natural product halichondrin B. Whereas its mechanism of action has not …

Overexpression of βIII-tubulin is associated with resistance to tubulin-binding agents (TBA)
in a range of tumor types. We previously showed that small interfering RNA silencing of βIII-…

The epothilones are a group of novel microtubule-targeted, antimitotic compounds that have
a paclitaxel-like, assembly enhancing effect on tubulin in vitro as well as in cultured cells. …

As Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to spread,
characterization of its antibody epitopes, emerging strains, related coronaviruses, and even …

T follicular helper (T FH ) cells are the conventional drivers of protective, germinal center (GC)–based
antiviral antibody responses. However, loss of T FH cells and GCs has been …

2-Methoxyestradiol (2ME2), a metabolite of estradiol-17β, is a novel antimitotic and
antiangiogenic drug candidate in phase I and II clinical trials for the treatment of a broad range of …